Predictors of Differential Response to Induction Therapy in High-Risk Neuroblastoma: A Report from the Children’s Oncology Group (COG)

di Pinto, Navin, Naranjo, Arlene, Hibbitts, Emily, Kreissman, Susan G., Granger, M. Meaghan, Irwin, Meredith S., Bagatell, Rochelle, London, Wendy B., Greengard, Emily G., Park, Julie R., DuBois, Steven G.
Pubblicato in Eur J Cancer (2019)

Association of MYCN Copy Number with Clinical Features, Tumor Biology, and Outcomes in Neuroblastoma: A Report from the Children’s Oncology Group

di Campbell, Kevin, Gastier-Foster, Julie M., Mann, Meegan, Naranjo, Arlene, Van Ryn, Collin, Bagatell, Rochelle, Matthay, Katherine K., London, Wendy B., Irwin, Meredith S., Shimada, Hiroyuki, Granger, M. Meaghan, Hogarty, Michael D., Park, Julie R., DuBois, Steven G.
Pubblicato in Cancer (2017)

Racial and Ethnic Differences in Communication and Care for Children With Advanced Cancer

di Mack, Jennifer W., Uno, Hajime, Twist, Clare J., Bagatell, Rochelle, Rosenberg, Abby R., Marachelian, Araz, Granger, M. Meaghan, Bender, Julia Glade, Baker, Justin N., Park, Julie R., Cohn, Susan L., Fernandez, Jorge H., Diller, Lisa R., Shusterman, Suzanne
Pubblicato in J Pain Symptom Manage (2020)

Unrealistic Parental Expectations for Cure in Poor-Prognosis Childhood Cancer

di Mack, Jennifer W., Cronin, Angel M., Uno, Hajime, Shusterman, Suzanne, Twist, Clare J., Bagatell, Rochelle, Rosenberg, Abby, Marachelian, Araz, Granger, M. Meaghan, Bender, Julia Glade, Baker, Justin N., Park, Julie, Cohn, Susan L., Levine, Alyssa, Taddei, Sarah, Diller, Lisa R.
Pubblicato in Cancer (2019)

Phase 1 Study of Vorinostat as a Radiation Sensitizer with (131)I-Metaiodobenzylguanidine ((131)I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma

di DuBois, Steven G., Groshen, Susan, Park, Julie R., Haas-Kogan, Daphne A., Yang, Xiaodong, Geier, Ethan, Chen, Eugene, Giacomini, Kathy, Weiss, Brian, Cohn, Susan L., Granger, M. Meaghan, Yanik, Gregory A., Hawkins, Randall, Courtier, Jesse, Jackson, Hollie, Goodarzian, Fariba, Shimada, Hiroyuki, Czarnecki, Scarlett, Tsao-Wei, Denice, Villablanca, Judith G., Marachelian, Araz, Matthay, Katherine K.
Pubblicato in Clin Cancer Res (2015)

Phase 2 Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

di DuBois, Steven G., Mosse, Yael P., Fox, Elizabeth, Kudgus, Rachel A., Reid, Joel M., McGovern, Renee, Groshen, Susan, Bagatell, Rochelle, Maris, John M., Twist, Clare J., Goldsmith, Kelly, Granger, M. Meaghan, Weiss, Brian, Park, Julie R., Macy, Margaret E., Cohn, Susan L., Yanik, Greg, Wagner, Lars, Hawkins, Randall, Courtier, Jesse, Lai, Hollie, Goodarzian, Fariba, Shimada, Hiroyuki, Boucher, Najee, Czarnecki, Scarlett, Luo, Chunqiao, Tsao-Wei, Denice D., Matthay, Katherine K., Marachelian, Araz
Pubblicato in Clin Cancer Res (2018)